Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-142786)

Filing Details

Accession Number:: 0001209191-16-142786
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-09-26 16:23:10
Reporting Period:: 2016-09-22

Filing Date:: 2016-09-26
Accepted Time:: 2016-09-26 16:23:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
873303	Sarepta Therapeutics Inc.	SRPT	Pharmaceutical Preparations (2834)	930797222

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1522780	Md M. Edward Kaye	215 First Street Suite 415 Cambridge MA 02142	President, Ceo & Cmo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-09-22	40,179	$8.28	117,162	No	4	M	Direct
Common Stock	Disposition	2016-09-22	40,179	$60.00	76,983	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Options (right to buy)	Disposition	2016-09-22	40,179	$8.28	40,179	$13.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
40,179	2012-06-20	2021-06-20	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.